Source: Eur Respir J, 50 (3) 1700891; 10.1183/13993003.00891-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Arthur Fournier, Christine Bernard, Wladimir Sougakoff, Sylvie Quelet, Fadi Antoun, Cécile Charlois-Ou, Isabelle Dormant, Marie-Odile Dufour, Nora Hocine, Vincent Jarlier, Nicolas Veziris. Neither genotyping nor contact tracing allow correct understanding of multidrug-resistant tuberculosis transmission. Eur Respir J, 50 (3) 1700891; 10.1183/13993003.00891-2017

Member's Comments

No comment yet.

Related content which might interest you: Extent of transmission captured by contact tracing in a tuberculosis high endemic setting Source: Eur Respir J , 49 (3) 1601851; DOI: 10.1183/13993003.01851-2016 Year: 2017 Improved tracking of nosocomial transmission of multidrug resistant M. tuberculosis with a novel T cell-based test Source: Eur Respir J 2003; 22: Suppl. 45, 167s Year: 2003 Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak Source: Eur Respir J, 51 (6) 1702313; 10.1183/13993003.02313-2017 Year: 2018 Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST. Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Standardised PCR-based molecular epidemiology of tuberculosis Source: Eur Respir J 2008; 31: 1077-1084 Year: 2008 Rapid detection of multi-drug-resistant tuberculosis (MDR-TB) in one day using the new molecular-biological test genotype MTBDRÔ Source: Eur Respir J 2006; 28: Suppl. 50, 290s Year: 2006 Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries Source: Eur Respir J, 51 (6) 1800387; 10.1183/13993003.00387-2018 Year: 2018 Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city Source: Eur Respir J 2013; 41: 901-908 Year: 2013 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission Source: Eur Respir J, 55 (3) 1901888; 10.1183/13993003.01888-2019 Year: 2020 Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 1285 Year: 2006 In vitro susceptibility testing and totally drug-resistant tuberculosis Source: Eur Respir J 2013; 42: 292 Year: 2013 In vitro susceptibility testing and totally drug-resistant tuberculosis Source: Eur Respir J 2013; 42: 291-292 Year: 2013 A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017 Year: 2017 Efficiency of molecular methods for epidemiological investigation in tuberculosis (TB) Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 The WHO strategy for TB control and elimination Source: Eur Respir Mon 2012; 58: 242-253 Year: 2012 Cost-optimisation of screening for latent tuberculosis in close contacts Source: Eur Respir J 2006; 28: 35-44 Year: 2006 HIV and multidrug-resistant tuberculosis: overlapping epidemics Source: Eur Respir J 2014; 44: 251-254 Year: 2014